Navigation


Glossary | Articles/Abstracts | Curricula Vitae | Additional Resources

Recent Articles & Abstracts

The following are recently published articles and abstracts generated by Dr. Grimm.

  • Dr. Peter Grimm. “Guidelines for Physicians Regarding Prostate Cancer Screening”. The Bulletin, King County Medical Society, September/October 2010. “Prostate cancer (PC) is the second leading cause of cancer-related mortality in men, with approximately 28,000 deaths per year. Screening for PC with the prostate-specific antigen (PSA) test carries some controversy, and patient questions arise about how to interpret the test results, as well as what can be done to mitigate the risk.”

Other Articles & Abstracts

The following is a partial list of articles and abstracts generated by Drs. Peter Grimm and John Sylvester.

For reprints or a complete bibliography, please email: info@prostatecancertreatmentcenter.com.

  1. Peter D. Grimm D.O., John E. Sylvester M.D., et al. “Low and Intermediate Risk Prostate Cancer – Comparative Effectiveness of Brachytherapy, Cryotherapy, External Beam Radio Therapy, HIFU, Proton Therapy, Radical Prostatectomy and Robot Assisted Radical Prostatectomy”, accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  2. John E. Sylvester M.D., Peter D. Grimm D.O., Jason Wong M.D., et al. “15 year Biochemical Relapse-Free Survival following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience,” accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  3. Jason Wong M.D., John E. Sylvester M.D., Peter D. Grimm D.O., et al. “First report on the use of a thinner I125 radioactive seed that fits into 20 gauge needles for permanent seed prostate brachytherapy: A report on post-implant dosimetry and acute toxicity,” accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  4. Jason Wong M.D., John E. Sylvester M.D., Peter D. Grimm D.O., et al. “First report on the use of a thinner I125 radioactive seed that fits into 20 gauge needles for permanent seed prostate brachytherapy: A report on post-implant dosimetry and acute toxicity,” accepted for publication and presentation at the Canadian Association of Radiation Oncologists Annual Meeting, abstract, Toronto, CA, November, 2009.
  5. John E. Sylvester, Peter D. Grimm, Jason Wong, et al. “Prostate brachytherapy biochemical relapse free survival outcomes in intermediate risk prostate cancer patients,” Brachytherapy abstract, Vol. 8, No. 2, pp. 140, May 30-June 2, 2009.
  6. John E. Sylvester, Jason Wong, Erik Torgerson, et al. “Randomized trial comparing intra-operative flexible, rigid and no cystoscopy after prostate brachytherapy,” Brachytherapy abstract, Vol. 8, No. 2, pp. 168, May 30-June 2, 2009.
  7. Gregory S. Merrick, Zachariah A. Allen, John E. Sylvester. “Post-implant rectal dosimetry is not dependent on Pd103 or I125 seed activity,” Brachytherapy abstract, Vol. 8, No. 2, pp. 125, May 30-June 2, 2009.
  8. Sylvester JE, Grimm PD, Eulau SM, et al. “Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes,” Brachytherapy 2009 Apr-Jun;8(2):197-206.
  9. Loiselle CR, Waheed M, Sylvester J, et al. “Analysis of the Pro-Qura Database: rectal dose, implant quality and brachytherapist’s experience,” Brachytherapy 2009 Jan-Mar; 8(1):34-9.
  10. Orio PF 3rd, Merrick GS, Grimm P, Blasko J, Sylvester J, Allen ZA, Butler WM, Chaudhry UU. “Effects of the time interval between prostate brachytherapy and postimplant dosimetric evaluation in community practice: analysis of Pro-Qura database,” Am J Clin Oncology 2008 Dec 31(6):523-31.
  11. Tward JD, Sylvester JE, Grimm PD, Schrieve DC “The Risk of Second Primary malignancies Following Brachytherapy Monotherapy, External Beam Plus Brachytherapy, or Radical Prostatectomy for Prostate Cancer” International Journal of Radiation Oncology Biology Physics;2008, 72: (1):S208
  12. John Sylvester, Peter D. Grimm, Stephen M. Eulua, Robert K. Takamiya, Devi Naidoo. “Permanent Prostate Brachytherapy Preplanned technique: The modern Seattle Method Step by Step and Dosimetric Outcomes,” 2008 World Congress of Brachytherapy abstract, May 3-6, 2008. Brachytherapy, Vol. 7, No. 2, April-June 2008.
  13. C. Louiselle, G.S. Merrick, J. Sylvester, P. Grimm, S. Eulau, M. Waheed, Z.A. Allen, W.M. Butler. “Analysis of the Pro-Qura Database: Implant Quality, Brachytherapist Experience and Rectal Dose Parameters,” ASTRO 50th Annual Meeting abstract, Boston, MA, September 21-25, 2008. International Journal of Radiation Oncology Biology Physics; 72: (1): S326.
  14. Jesse N. Aronowitz, Juanita M. Crook, Jeff M. Michalski, John E. Sylvester, Gregory S. Merrick, Christie Mawson, David Pratt, Devi Naidoo, Wayne M. Butler, Kathryn Karolczuk. “Inter-institutional variation of implant activity for permanent prostate brachytherapy,” Brachytherapy 2008;7:297-300.
  15. John Sylvester, Gregory S. Merrick, Peter Grimm, et al: “Influence of Pro-Qura Feedback on Rectal Dosimetry Following Permanent Prostate Brachytherapy,” 2008 World Congress of Brachytherapy, May 3-6, 2008. Brachytherapy abstract, Vol. 7, No. 2, pp. 121, April-June 2008.
  16. Allen Z, Merrick GS, Grimm P, Blasko J, Sylvester J, Butler W, Chaudry UU, Sitter M. “Influence of Pro-Qura-Generated Plans on Postimplant Dosimetric Quality: A Review of a Multi-Institutional Database,” Medical Dosimetry, 2008 Autumn; 33(3):206-14.
  17. John Sylvester, Gregory S. Merrick, Peter Grimm, et al: “Influence of Pro-Qura Feedback on Rectal Dosimetry Following Permanent Prostate Brachytherapy,” 2008 World Congress of Brachytherapy, May 3-6, 2008. Brachytherapy, Vol. 7, No. 2, pp. 121, April-June 2008.
  18. John Sylvester, Tricia Zeller, Chris J. Hennessy, Steve Eulau, Peter Grimm. Overview of the Calypso® 4D Localization System™; American College of Radiation Oncology Practice Management Guide, American College of Radiation Oncology, Bethesda, MD 2008.
  19. Steven J. Frank, Peter D. Grimm, John E. Sylvester, Gregory S. Merrick, Brian J. Davis, Anthony Zeitman, Brian J. Moran, David C. Beyer, Mack Roach III, Daniel H. Clarke, Richard G. Stock, W. Robert Lee, Jeff M. Michalski, Kent E. Wallner, Mark Hurwitz, Louis Potters, Deborah A. Kuban, Bradley R. Prestidge, Robyn Vera, Shannon Hathaway, John C. Blasko. “Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: A survey of practice patterns in the United States,” Brachytherapy 2007; 6(1):2-8.
  20. Merrick GS, Grimm PD, Sylvester J, Blasko JC, et al. “Initial analysis of Pro-Qura: A multi-institutional database of prostate brachytherapy dosimetry,” Brachytherapy 2007; 6(1):9-15.
  21. Sylvester JE, Grimm PG, Blasko JC, Millar J, Orio III PF, Skoglund S, Galbreath RW, Merrick G, “15-Year Biochemical Relapse Free Survival in Clinical Stage T1-T3 Prostate Cancer Following Combined External Beam Radiotherapy and Brachytherapy; Seattle Experience,” International Journal of Radiation Oncology Biology Physics 2007;67:1:57-64.
  22. Liauw SL, Sylvester JE, Morris CG, Blasko JC, Grimm PD, “Second Malignancies After Prostate Brachytherapy: Incidence of Bladder and Colorectal Cancers in Patients with Fifteen Years of Potential Follow-up,” International Journal of Radiation Oncology Biology Physics 2006;66:3:669-673.
  23. Grimm PG, Merrick GS, Butler WM, Blasko JC, Sylvester JE, Allen ZA, Chaudhry U, Mazza A. “Preliminary Analysis of the Pro-Qura Multi-Institutional Prostate Brachytherapy Dosimetry Database,” Brachytherapy abstract Vol. 5, No 2, pp. 91, April-June 2006.
  24. Sylvester JE, Blasko JC, Grimm PD, et al; “Fifteen Year Outcomes of Prostate Cancer Patients Treated With Brachytherapy,” BJU abstract 2005.
  25. Sylvester JE; The Seattle Prostate Institute Approach to Treatment Planning for Permanent Implants; In Dicker AP et al (ed), Basic and Advanced Techniques in Prostate Brachytherapy, Martin Dunitz Taylor & Francis Group, Independence, KY, 2005.
  26. Sylvester JE, Grimm PD, Malmgren JA: “Fifteen Year Biochemical Relapse Free Survival Outcomes of Patients With Localized Prostate Cancer Treated With Brachytherapy”, British Journal of Urology International abstract, February 2005.
  27. Sylvester JE, Valicenti RK; Review of article “Hormonal Therapy Plus External-Beam Radiation and Brachytherapy for Prostate Cancer,” Oncology Vol. 19, No 1, pp.36-39.
  28. Grimm PD, Sylvester JE, “Advances in Brachytherapy,” Reviews in Urology; Vol. 6, Supp 4, pp. S37-S48, 2004.
  29. Sylvester JE, Blasko JC, Grimm PD, et al; “Fifteen Year Follow-up of the First Cohort of Localized Prostate Cancer Patients Treated With Brachytherapy,” Journal of Clinical Oncology; 22:14S:4567, 2004.
  30. Grimm PD, Blasko JC, Sylvester JE, et al. “Technical Improvement in Permanent Seed Implantation: A Two Stage Brachytherapy System. Description and Comparison With Current Technique,” Brachytherapy, Vol. 3, No1, pp. 34-40, May 2004.
  31. Sylvester JE. “Prostate Brachytherapy,” North American Pharmaco Therapy, Business Briefing; pp. 51-53, Feb 2004.
  32. Grimm PG, Blasko JC, Sylvester JE, The Prostate Cancer Treatment Book. New York. McGraw Hill. 2004.
  33. Sylvester J., Blasko J., Grimm P., “Transrectal Ultrasound-Guided Prostate Brachytherapy,” in Image-Guided Diagnosis and Treatment of Cancer (D’Amico A, Loeffler J., Harris J. eds), Totowa, Humana Press, 2003, pp. 119-154.
  34. Han BH, Wallner K, Merrick G, Butler W, Sutlief S, Sylvester J. “Prostate Brachytherapy Seed Identification On Post-Implant TRUS Images,” Medical Physics, 2003 May; 30(5):898-900.

Recent Publications and Presentations

  1. Peter D. Grimm D.O., John E. Sylvester M.D., et al. “Low and Intermediate Risk Prostate Cancer – Comparative Effectiveness of Brachytherapy, Cryotherapy, External Beam Radio Therapy, HIFU, Proton Therapy, Radical Prostatectomy and Robot Assisted Radical Prostatectomy”, accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  2. Jason Wong M.D., John E. Sylvester M.D., Peter D. Grimm D.O., et al. “First report on the use of a thinner I125 radioactive seed that fits into 20 gauge needles for permanent seed prostate brachytherapy: A report on post-implant dosimetry and acute toxicity,” accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  3. Jason Wong M.D., John E. Sylvester M.D., Peter D. Grimm D.O., et al. “First report on the use of a thinner I125 radioactive brachytherapy: A report on post-implant dosimetry and acute toxicity,” accepted for publication and presentation at the Canadian Association of Radiation Oncologists Annual Meeting, abstract, Toronto, CA, November, 2009.
  4. John E. Sylvester M.D., Peter D. Grimm D.O., Jason Wong M.D., et al. “15 year Biochemical Relapse-Free Survival following I125 Prostate Brachytherapy in Clinically Localized Prostate Cancer: Seattle Experience,” accepted for publication and presentation at the 51st American Society for Radiation Oncology Annual Meeting, abstract, Chicago, IL, November 1-5, 2009.
  5. John E. Sylvester, Peter D. Grimm, Jason Wong, et al. “Prostate brachytherapy biochemical relapse free survival outcomes in intermediate risk prostate cancer patients,” Brachytherapy abstract, Vol. 8, No. 2, pp. 140, May 30-June 2, 2009.
  6. John E. Sylvester, Jason Wong, Erik Torgerson, et al. “Randomized trial comparing intra-operative flexible, rigid and no cystoscopy after prostate brachytherapy,” Brachytherapy abstract, Vol. 8, No. 2, pp. 168, May 30-June 2, 2009.
  7. Gregory S. Merrick, Zachariah A. Allen, John E. Sylvester. “Post-implant rectal dosimetry is not dependent on Pd103 or I125 seed activity,” Brachytherapy abstract, Vol. 8, No. 2, pp. 125, May 30-June 2, 2009.
  8. Sylvester JE, Grimm PD, Eulau SM, et al. “Permanent prostate brachytherapy preplanned technique: The modern Seattle method step-by-step and dosimetric outcomes,” Brachytherapy 2009 Apr-Jun;8(2):197-206.
  9. Loiselle CR, Waheed M, Sylvester J, et al. “Analysis of the Pro-Qura Database: rectal dose, implant quality and brachytherapist’s experience,” Brachytherapy 2009 Jan-Mar; 8(1):34- 38.